ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis

Authors: Ali A. Habib, Kristl G. Claeys, Vera Bril, Yessar Hussain, Kelly Gwathmey, Gregory Sahagian, Elena Cortés‐Vicente, Edward Brauer, Deborah Gelinas, Anne Sumbul, Rosa H. Jimenez, Daniela Hristova, Delphine Masschaele, Renato Mantegazza, Andreas Meisel, Shahram Attarian, the ADAPT NXT Study Group

Source: Ann Clin Transl Neurol
Annals of Clinical and Translational Neurology, Vol 12, Iss 6, Pp 1162-1170 (2025)

Subject Terms: Male, Adult, ADAPT NXT Study Group, Clinical Neurology, MULTICENTER, Neurosciences. Biological psychiatry. Neuropsychiatry, myasthenia gravis activities of daily living, Drug Administration Schedule, Myasthenia Gravis, Activities of Daily Living, MANAGEMENT, Humans, generalized myasthenia gravis, RC346-429, Aged, Science & Technology, neonatal Fc receptor, Neurosciences, 1103 Clinical Sciences, Middle Aged, EFFICACY, 5203 Clinical and health psychology, INTERNATIONAL CONSENSUS GUIDANCE, Treatment Outcome, SAFETY, 3209 Neurosciences, efgartigimod, Female, Neurosciences & Neurology, Neurology. Diseases of the nervous system, 1109 Neurosciences, Life Sciences & Biomedicine, RC321-571, Research Article

Access URL: https://pubmed.ncbi.nlm.nih.gov/40223516
https://doaj.org/article/579ed22d30e9489ea039ace6079d6d15
https://lirias.kuleuven.be/handle/20.500.12942/769529
https://doi.org/10.1002/acn3.70051

Recommendations for the management of myasthenia gravis in Belgium

Authors: De Bleecker, Jan L, Remiche, Gauthier, Alonso-Jiménez, Alicia, Van Parys, Vinciane, Bissay, Véronique, DELSTANCHE, Stéphanie, Claeys, Kristl G

Contributors: Janssen Pharmaceutica, UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - (SLuc) Service de neurologie, Neuroprotection & Neuromodulation, Clinical sciences, Neurology

Source: Acta Neurol Belg
Acta neurologica Belgica, Vol. 124, no.4, p. 1371-1383 (2024)
Acta neurologica Belgica

Subject Terms: Clinical Neurology, Guideline, Sciences de la santé humaine, DOUBLE-BLIND, 03 medical and health sciences, 0302 clinical medicine, ECULIZUMAB, Belgium, Neurologie, Myasthenia Gravis, Humans, Human health sciences, Treatment recommendations, Myasthenia gravis, Science & Technology, Neurology & Neurosurgery, Clinical management, Myasthenia Gravis/diagnosis, Neurosciences, 3202 Clinical sciences, Disease Management, 1103 Clinical Sciences, EFFICACY, INTERNATIONAL CONSENSUS GUIDANCE, 3. Good health, PREGNANCY, Neurology, SAFETY, Therapies, 3209 Neurosciences, Practice Guidelines as Topic, Human medicine, Myasthenia Gravis/therapy, Neurology (clinical), Neurosciences & Neurology, Practice Guidelines as Topic/standards, 1109 Neurosciences, Life Sciences & Biomedicine

File Description: 1 full-text file(s): application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38649556
https://hdl.handle.net/2078.1/293807
https://repository.uantwerpen.be/docstore/d:irua:23651
https://hdl.handle.net/10067/2060290151162165141
https://biblio.vub.ac.be/vubir/recommendations-for-the-management-of-myasthenia-gravis-in-belgium(1b91b9a5-7124-4a65-8c48-93f766dc4d92).html

Effects of comorbid diseases on clinical outcomes in patients with myasthenia gravis

Authors: Huseyin Nezih Ozdemir, Hatice Karasoy, Ayse Nur Yuceyar, Ozgul Ekmekci

Source: Neurological Sciences. 44:2923-2931

Subject Terms: Male, Thymoma, Autoimmune-Diseases, MGFA, Thymus Neoplasms, Comorbid diseases, International Consensus Guidance, Thymectomy, Antibodies, 3. Good health, Management, Cross-Sectional Studies, Treatment Outcome, Myasthenia Gravis, Humans, Female, Myasthenia gravis, Outcome, Retrospective Studies

Access URL: https://pubmed.ncbi.nlm.nih.gov/36943588
https://hdl.handle.net/11454/89507
https://doi.org/10.1007/s10072-023-06750-8
https://hdl.handle.net/11454/101905
https://doi.org/10.1007/s10072-023-06750-8